OpenURL Connection Search

Select item for more details and to access through your institution.

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.
Published in:
2009
By:
- Macías J;
- Orihuela F;
- Rivero A;
- Viciana P;
- Márquez M;
- Portilla J;
- Ríos MJ;
- Muñoz L;
- Pasquau J;
- Castaño MA;
- Abdel-Kader L;
- Pineda JA;
- Hepatip Study Group;
- Macías, Juan;
- Orihuela, Francisco;
- Rivero, Antonio;
- Viciana, Pompeyo;
- Márquez, Manuel;
- Portilla, Joaquín;
- Ríos, María J
Publication type:
journal article
A clinical trial to compare the quality of life of HIV+ patients who start monotherapy with LPV/r versus continuing triple therapy with a boosted PI.
Published in:
Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18355
By:
- Pasquau, J;
- Hidalgo, C;
- Vergara, A;
- Montes, M;
- Vergas, J;
- Sanjoaquín, I;
- Hernández-Quero, J;
- Aguirrebengoa, K;
- Orihuela, F;
- Rodríguez-Baño, J;
- Imaz, A;
- García-Vallecillos, C
Publication type:
Article
Reasons for antiretroviral treatment changes in Spanish HIV 1 patients in 2011: SWITCH AUDIT study.
Published in:
Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18345
By:
- Tasias, M;
- Viciana, P;
- Deig, E;
- Arranz, J;
- Pasquau, J;
- Vera, F;
- Pujol, E;
- Vergas, J;
- Bernardino, J;
- Pedrol, E
Publication type:
Article
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
Published in:
HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
By:
- Poveda, E;
- Hernández‐Quero, J;
- Pérez‐Elías, MJ;
- Ribas, MA;
- Martínez‐Madrid, OJ;
- Flores, J;
- Navarro, J;
- Gutiérrez, F;
- García‐Deltoro, M;
- Imaz, A;
- Ocampo, A;
- Artero, A;
- Blanco, F;
- Bernal, E;
- Pasquau, J;
- Mínguez‐Gallego, C;
- Pérez, N;
- Aiestaran, A;
- García, F;
- Paredes, R
Publication type:
Article
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.
Published in:
HIV Medicine, 2014, v. 15, n. 7, p. 417, doi. 10.1111/hiv.12129
By:
- Macías, J;
- Recio, E;
- Márquez, M;
- García, C;
- Jiménez, P;
- Merino, D;
- Muñoz, L;
- Pasquau, J;
- Ojeda, G;
- Bancalero, P;
- Chueca, N;
- Pineda, JA
Publication type:
Article
Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors.
Published in:
Quality of Life Research, 2005, v. 14, n. 5, p. 1301, doi. 10.1007/s11136-004-4715-x
By:
- Perez, I. Ruiz;
- Bañ, J. Rodriguez;
- Lopez Ruz, M. A.;
- Del Arco Jimenez, A.;
- Prados, M. Causse;
- Liaño, J. Pasquau;
- Rico, P. Martin;
- De Ia Torre Lima, J.;
- Pardal, J. L. Prada;
- Gomez, M. Lopez;
- Muñoz, N.;
- Morales, D.;
- Marcos, M.
Publication type:
Article
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Published in:
2020
By:
- Casadellà, M;
- Santos, J R;
- Noguera-Julian, M;
- Micán-Rivera, R;
- Domingo, P;
- Antela, A;
- Portilla, J;
- Sanz, J;
- Montero-Alonso, M;
- Navarro, J;
- Masiá, M;
- Valcarce-Pardeiro, N;
- Ocampo, A;
- Pérez-Martínez, L;
- Pasquau, J;
- Vivancos, M J;
- Imaz, A;
- Carmona-Oyaga, P;
- Muñoz-Medina, L;
- Villar-García, J
Publication type:
journal article
Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).
Published in:
2017
By:
- Perez-Molina, J. A.;
- Rubio, R.;
- Rivero, A.;
- Pasquau, J.;
- Suárez-Lozano, I.;
- Riera, M.;
- Estébanez, M.;
- Palacios, R.;
- Sanz-Moreno, J.;
- Troya, J.;
- Mariño, A.;
- Antela, A.;
- Navarro, J.;
- Esteban, H.;
- Moreno, S.;
- GeSIDA 7011 Study Group
Publication type:
journal article
Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.
Published in:
2010
By:
- López-Cortés LF;
- Viciana P;
- Ruiz-Valderas R;
- Pasquau J;
- Ruiz J;
- Lozano F;
- Merino D;
- Vergara A;
- Terrón A;
- González L;
- Rivero A;
- Muñoz-Sanz A
Publication type:
Journal Article

Found: 9